Mia M Gaudet

Summary

Affiliation: Albert Einstein College of Medicine
Country: USA

Publications

  1. pmc Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
    Roger L Milne
    Genetic and Molecular Epidemiology Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre CNIO, Madrid, 28029, Spain
    Breast Cancer Res 12:R110. 2010
  2. pmc No association between FTO or HHEX and endometrial cancer risk
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 19:2106-9. 2010
  3. pmc Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Cancer Epidemiol 34:580-6. 2010
  4. pmc DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Cancer Epidemiol Biomarkers Prev 18:3036-43. 2009
  5. ncbi request reprint IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk
    Jing Shen
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA
    Breast Cancer Res Treat 99:1-7. 2006
  6. ncbi request reprint MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk
    Jing Shen
    Department of Environmental Health Sciences, Columbia University, New York, NY 10032, USA
    Carcinogenesis 26:2131-7. 2005
  7. pmc Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
    Tomas Kirchhoff
    Memorial Sloan Kettering Cancer Center MSKCC Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America TK, MG, KO Department of Environmental Medicine, New York University Cancer Institute, New York University, New York, New York, United States of America TK, American Cancer Society, Atlanta, Georgia, United States of America MG
    PLoS ONE 7:e35706. 2012
  8. ncbi request reprint OGG1 polymorphisms and breast cancer risk
    Pavel Rossner
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA
    Cancer Epidemiol Biomarkers Prev 15:811-5. 2006
  9. ncbi request reprint A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users
    Xinran Xu
    Departments of Community and Preventive Medicine and Epidemiology and Medicine, Columbia University, New York, NY, USA
    Am J Clin Nutr 85:1098-102. 2007
  10. pmc Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
    Mia M Gaudet
    Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Epidemiol Biomarkers Prev 18:1610-6. 2009

Detail Information

Publications24

  1. pmc Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
    Roger L Milne
    Genetic and Molecular Epidemiology Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre CNIO, Madrid, 28029, Spain
    Breast Cancer Res 12:R110. 2010
    ....
  2. pmc No association between FTO or HHEX and endometrial cancer risk
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 19:2106-9. 2010
    ....
  3. pmc Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Cancer Epidemiol 34:580-6. 2010
    ..S. women with prospectively-collected serum samples obtained in the mid 1970s and followed for up to 25 years...
  4. pmc DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations
    Mia M Gaudet
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Cancer Epidemiol Biomarkers Prev 18:3036-43. 2009
    ..In contrast to CpG islands, ESR1 promoter C showed a wider range of methylation levels and inverse associations with ERalpha and PR expression...
  5. ncbi request reprint IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk
    Jing Shen
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA
    Breast Cancer Res Treat 99:1-7. 2006
    ..Additional studies focused on the biological function of the variant-G allele and interactions with other genetic polymorphisms are necessary to confirm our findings...
  6. ncbi request reprint MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk
    Jing Shen
    Department of Environmental Health Sciences, Columbia University, New York, NY 10032, USA
    Carcinogenesis 26:2131-7. 2005
    ....
  7. pmc Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
    Tomas Kirchhoff
    Memorial Sloan Kettering Cancer Center MSKCC Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America TK, MG, KO Department of Environmental Medicine, New York University Cancer Institute, New York University, New York, New York, United States of America TK, American Cancer Society, Atlanta, Georgia, United States of America MG
    PLoS ONE 7:e35706. 2012
    ..89, 95%CI 0.80-1.00, p = 0.048), indicating a potential protective effect of this allele. These data suggest that that 6q22.33 confers a weak effect on breast cancer risk...
  8. ncbi request reprint OGG1 polymorphisms and breast cancer risk
    Pavel Rossner
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA
    Cancer Epidemiol Biomarkers Prev 15:811-5. 2006
    ..In addition, data on functionality of these polymorphisms are crucial to understand if these modest differences are important...
  9. ncbi request reprint A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users
    Xinran Xu
    Departments of Community and Preventive Medicine and Epidemiology and Medicine, Columbia University, New York, NY, USA
    Am J Clin Nutr 85:1098-102. 2007
    ..Folic acid from multivitamins needs to be reduced by DHFR before it participates in cellular reactions...
  10. pmc Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
    Mia M Gaudet
    Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer Epidemiol Biomarkers Prev 18:1610-6. 2009
    ....
  11. ncbi request reprint Plasma protein carbonyl levels and breast cancer risk
    Pavel Rossner
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA
    J Cell Mol Med 11:1138-48. 2007
    ..8, 95% CI = 1.2-2.6) compared to women with levels below the median for both markers of oxidative stress. In summary, our results suggest that increased plasma protein carbonyl levels may be associated with breast cancer risk...
  12. pmc A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies
    Xiaonan Xue
    Division of Biostatistics, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 22:275-85. 2013
    ..However, the validity, accuracy, and efficiency of this approach for prospective cohort studies have not been formally evaluated...
  13. pmc Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project
    Heather Greenlee
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
    Cancer 115:3271-82. 2009
    ..The authors of this report analyzed the prevalence of and factors associated with antioxidant supplement use during breast cancer (BC) treatment among women who participated in the Long Island Breast Cancer Study Project...
  14. pmc Germline BRCA mutations denote a clinicopathologic subset of prostate cancer
    David J Gallagher
    Clinical Genetics Service, Department of Medicine, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Cancer Res 16:2115-21. 2010
    ..Increased prostate cancer risk has been reported for BRCA mutation carriers, but BRCA-associated clinicopathologic features have not been clearly defined...
  15. ncbi request reprint Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk
    Pavel Rossner
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Cancer Epidemiol Biomarkers Prev 15:639-44. 2006
    ..In summary, our results suggest that urinary markers of lipid peroxidation and oxidative DNA damage may be associated with breast cancer risk...
  16. pmc Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
    Mia M Gaudet
    Department of Epidemiology and Population Health and Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, New York, New York, United States of America
    PLoS Genet 6:e1001183. 2010
    ..28, 95% CI 1.18-1.39, ). These results indicate that SNPs that modify BRCA2 penetrance identified by an agnostic approach thus far are limited to variants that also modify risk of sporadic BRCA2 wild-type breast cancer...
  17. ncbi request reprint Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk
    Jing Shen
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Cancer Epidemiol Biomarkers Prev 14:336-42. 2005
    ..Further understanding of the biological function of XRCC1 variants and their interactions with PAH-DNA adducts, antioxidants, and other genes in the pathway are needed...
  18. pmc Mutations in p53, p53 protein overexpression and breast cancer survival
    Pavel Rossner
    Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA
    J Cell Mol Med 13:3847-57. 2009
    ....
  19. pmc Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium
    Mia M Gaudet
    Department of Epidemiology and Population Health and of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
    Int J Epidemiol 39:1091-102. 2010
    ....
  20. doi request reprint The 6q22.33 locus and breast cancer susceptibility
    Tomas Kirchhoff
    Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 18:2468-75. 2009
    ..Further functional studies of candidate genes are in progress, and a large replication analysis is being completed as part of an international consortium...
  21. pmc Susceptibility loci associated with prostate cancer progression and mortality
    David J Gallagher
    Department of Medicine, Clinical Genetics Service, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, Albert Einstein College of Medicine, New York, New York 10065, USA
    Clin Cancer Res 16:2819-32. 2010
    ..Prostate cancer is a heterogeneous disease with a variable natural history that is not accurately predicted by currently used prognostic tools...
  22. ncbi request reprint Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk
    Jiyoung Ahn
    Department of Epidemiology, Roswell Park Cancer Institute, Buffalo, New York, USA
    Cancer Res 64:7634-9. 2004
    ....
  23. pmc A prospective investigation of coffee drinking and endometrial cancer incidence
    Marc J Gunter
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA
    Int J Cancer 131:E530-6. 2012
    ..54, 95% CI, 0.41-0.72; P(trend) = 0.0005). Endometrial cancer incidence appears to be reduced among women that habitually drink coffee, an association that does not differ according to caffeine content...
  24. ncbi request reprint The epidemiology of gastric cancer
    Mary Beth Terry
    Columbia University Mailman School of Public Health, Department of Epidemiology, New York, NY 10032, USA
    Semin Radiat Oncol 12:111-27. 2002
    ..Future epidemiologic studies that include information on site of origin as well as molecular markers promise to yield more homogeneous classification of case groups, which will enhance identification of underlying disease processes...